Your browser doesn't support javascript.
loading
Classification and regression tree analysis of acute-on-chronic hepatitis B liver failure: Seeing the forest for the trees.
Shi, K-Q; Zhou, Y-Y; Yan, H-D; Li, H; Wu, F-L; Xie, Y-Y; Braddock, M; Lin, X-Y; Zheng, M-H.
Afiliação
  • Shi KQ; Department of Hepatology, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zhou YY; Institute of Hepatology, Wenzhou Medical University, Wenzhou, China.
  • Yan HD; Department of Cardiology, Jinhua Municipal Hospital, Jinhua, China.
  • Li H; Department of Infectious Diseases, Ningbo No. 2 Hospital, Ningbo, China.
  • Wu FL; Department of Intensive Care Unit, Tianjin Infectious Disease Hospital, Tianjin, China.
  • Xie YY; Department of Hepatology, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Braddock M; Institute of Hepatology, Wenzhou Medical University, Wenzhou, China.
  • Lin XY; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zheng MH; Global Medicines Development, AstraZeneca R&D, Loughborough, UK.
J Viral Hepat ; 24(2): 132-140, 2017 02.
Article em En | MEDLINE | ID: mdl-27686368
ABSTRACT
At present, there is no ideal model for predicting the short-term outcome of patients with acute-on-chronic hepatitis B liver failure (ACHBLF). This study aimed to establish and validate a prognostic model by using the classification and regression tree (CART) analysis. A total of 1047 patients from two separate medical centres with suspected ACHBLF were screened in the study, which were recognized as derivation cohort and validation cohort, respectively. CART analysis was applied to predict the 3-month mortality of patients with ACHBLF. The accuracy of the CART model was tested using the area under the receiver operating characteristic curve, which was compared with the model for end-stage liver disease (MELD) score and a new logistic regression model. CART analysis identified four variables as prognostic factors of ACHBLF total bilirubin, age, serum sodium and INR, and three distinct risk groups low risk (4.2%), intermediate risk (30.2%-53.2%) and high risk (81.4%-96.9%). The new logistic regression model was constructed with four independent factors, including age, total bilirubin, serum sodium and prothrombin activity by multivariate logistic regression analysis. The performances of the CART model (0.896), similar to the logistic regression model (0.914, P=.382), exceeded that of MELD score (0.667, P<.001). The results were confirmed in the validation cohort. We have developed and validated a novel CART model superior to MELD for predicting three-month mortality of patients with ACHBLF. Thus, the CART model could facilitate medical decision-making and provide clinicians with a validated practical bedside tool for ACHBLF risk stratification.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Apoio para a Decisão / Hepatite B Crônica / Insuficiência Hepática Crônica Agudizada Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Técnicas de Apoio para a Decisão / Hepatite B Crônica / Insuficiência Hepática Crônica Agudizada Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China